412 related articles for article (PubMed ID: 23574768)
1. Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.
Colizzi M; Costa R; Pace V; Todarello O
J Sex Med; 2013 Dec; 10(12):3049-58. PubMed ID: 23574768
[TBL] [Abstract][Full Text] [Related]
2. Attachment styles in transsexual patients and clinical and nonclinical control groups: a response.
Colizzi M
J Sex Med; 2014 Apr; 11(4):1093-1095. PubMed ID: 24754333
[No Abstract] [Full Text] [Related]
3. Attachment styles in transsexual patients and clinical and nonclinical control groups: comment on Colizzi et al.
Lawrence AA
J Sex Med; 2014 Apr; 11(4):1093-1095. PubMed ID: 24754332
[No Abstract] [Full Text] [Related]
4. Hormone-treated transsexuals report less social distress, anxiety and depression.
Gómez-Gil E; Zubiaurre-Elorza L; Esteva I; Guillamon A; Godás T; Cruz Almaraz M; Halperin I; Salamero M
Psychoneuroendocrinology; 2012 May; 37(5):662-70. PubMed ID: 21937168
[TBL] [Abstract][Full Text] [Related]
5. Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study.
Colizzi M; Costa R; Todarello O
Psychoneuroendocrinology; 2014 Jan; 39():65-73. PubMed ID: 24275005
[TBL] [Abstract][Full Text] [Related]
6. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
[TBL] [Abstract][Full Text] [Related]
7. Stigma and diurnal cortisol among transitioning transgender men.
DuBois LZ; Powers S; Everett BG; Juster RP
Psychoneuroendocrinology; 2017 Aug; 82():59-66. PubMed ID: 28511045
[TBL] [Abstract][Full Text] [Related]
8. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
[TBL] [Abstract][Full Text] [Related]
9. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
10. Cortical activation during mental rotation in male-to-female and female-to-male transsexuals under hormonal treatment.
Carrillo B; Gómez-Gil E; Rametti G; Junque C; Gomez A; Karadi K; Segovia S; Guillamon A
Psychoneuroendocrinology; 2010 Sep; 35(8):1213-22. PubMed ID: 20219285
[TBL] [Abstract][Full Text] [Related]
11. Determinants of quality of life in Spanish transsexuals attending a gender unit before genital sex reassignment surgery.
Gómez-Gil E; Zubiaurre-Elorza L; de Antonio IE; Guillamon A; Salamero M
Qual Life Res; 2014 Mar; 23(2):669-76. PubMed ID: 23943260
[TBL] [Abstract][Full Text] [Related]
12. [Psychiatric comorbidities in transsexualism: Study of a Lebanese transgender population].
Ibrahim C; Haddad R; Richa S
Encephale; 2016 Dec; 42(6):517-522. PubMed ID: 27017319
[TBL] [Abstract][Full Text] [Related]
13. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.
Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Guillamon A
J Sex Med; 2014 May; 11(5):1248-61. PubMed ID: 24617977
[TBL] [Abstract][Full Text] [Related]
14. Transgender men: clinical care and implications in reproductive medicine: introduction.
de Ziegler D; de Sutter P
Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
[TBL] [Abstract][Full Text] [Related]
15. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study.
Gorin-Lazard A; Baumstarck K; Boyer L; Maquigneau A; Gebleux S; Penochet JC; Pringuey D; Albarel F; Morange I; Loundou A; Berbis J; Auquier P; Lançon C; Bonierbale M
J Sex Med; 2012 Feb; 9(2):531-41. PubMed ID: 22145968
[TBL] [Abstract][Full Text] [Related]
16. Hormone treatment of the adult transsexual patient.
Gooren L
Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
[TBL] [Abstract][Full Text] [Related]
17. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria.
Fisher AD; Castellini G; Bandini E; Casale H; Fanni E; Benni L; Ferruccio N; Meriggiola MC; Manieri C; Gualerzi A; Jannini E; Oppo A; Ricca V; Maggi M; Rellini AH
J Sex Med; 2014 Mar; 11(3):709-19. PubMed ID: 24330520
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging differences in spatial cognition between men and male-to-female transsexuals before and during hormone therapy.
Schöning S; Engelien A; Bauer C; Kugel H; Kersting A; Roestel C; Zwitserlood P; Pyka M; Dannlowski U; Lehmann W; Heindel W; Arolt V; Konrad C
J Sex Med; 2010 May; 7(5):1858-67. PubMed ID: 19751389
[TBL] [Abstract][Full Text] [Related]
19. WHOQOL-100 Before and After Sex Reassignment Surgery in Brazilian Male-to-Female Transsexual Individuals.
Cardoso da Silva D; Schwarz K; Fontanari AM; Costa AB; Massuda R; Henriques AA; Salvador J; Silveira E; Elias Rosito T; Lobato MI
J Sex Med; 2016 Jun; 13(6):988-93. PubMed ID: 27117529
[TBL] [Abstract][Full Text] [Related]
20. Circulating nitric oxide levels increase after anti-androgen treatment in male-to-female transsexuals.
Valenti S; Fazzuoli L; Giusti M
J Endocrinol Invest; 2003 Jun; 26(6):522-6. PubMed ID: 12952365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
